Providence Health Care Research Institute

What Providence Health Care Research Institute does

Providence Health Care Research Institute, operating as Providence Research, is the research enterprise of Providence Health Care, a Catholic teaching hospital system headquartered in Vancouver, British Columbia. It is an academic health science centre affiliated with the University of British Columbia and Simon Fraser University, and the institute's president concurrently serves as Associate Dean, Research at UBC's Faculty of Medicine. Providence Research conducts patient-centred clinical research across cardiology, respirology, nephrology, addiction medicine, rehabilitation, pain management, and cardiac arrest, supported by infrastructure including the Mount Saint Joseph Hospital Phase 1 Clinical Trials Unit (B.C.'s only non-oncology Phase 1 CTU, opened September 2025), the Clinical Support and Research Centre (CSRC, under construction, expected to open in 2029), the Health Informatics Data Platform for de-identified real-time clinical data, a Simulation Centre with Extended Reality capabilities, wet labs, and a Research Biobank.

The research portfolio includes investigator-initiated studies, industry-sponsored clinical trials, and population-level research such as the Provincial Cardiac Arrest Registry, which captures roughly 8,000 out-of-hospital cardiac arrest events annually in B.C. Technology products include the Research Proposal Assistant, a GenAI tool deployed on Microsoft Azure-hosted LLMs to help researchers draft grant proposals, and AI-assisted wearable cardiac arrest detection algorithms with emergency alert functionality. Funding flows from federal and provincial grants (including a $48M Strategic Response Fund contribution from the Government of Canada for the CSRC), industry-sponsored clinical trial contracts, and philanthropic donations channeled through St. Paul's Foundation and the Carraresi Foundation.

Providence Research generates revenue through government research grants and competitive awards (CIHR, Michael Smith Health Research BC), industry-sponsored clinical trial contracts negotiated by its Contracts and Grants team, and philanthropic donations. The primary customer segments are clinician-researchers and physicians affiliated with Providence Health Care, clinical trial participants (including healthy volunteers at the MSJ CTU), academic and industry partners (UBC, SFU, Medtronic, Aspect Biosystems, Michael Smith Genome Sciences Centre), and the research support services internally. The go-to-market model is community- and institution-led: there is no commercial product sales motion, with research services funded through grants, contracts, and donations, and results disseminated via publications, monthly newsletters, the annual Research Review Magazine, events, and clinical integration at PHC hospital sites.

Name

Providence Health Care Research Institute

Legal name

Providence Health Care Research Institute

Website

https://providenceresearch.ca

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Providence Health Care Research Institute is the research enterprise of Providence Health Care, a Vancouver-based Catholic teaching hospital system. It conducts patient-centred clinical research across cardiology, nephrology, addiction medicine, and rehabilitation, supported by Phase 1 clinical trials infrastructure, wet labs, and a Health Informatics Data Platform, and is academically affiliated with UBC and SFU.

Ownership category

akta.pro rank

Product category

Clinical and Translational Health Research

NAICS

General Medical and Surgical Hospitals (6221)

SIC

Services-Health Services (8000), Services-Hospitals (8060)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Clinical research
• Clinical trials
• Translational medicine
• Academic health research
• Health informatics

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Research Grants and Funding: Federal, provincial, and foundation funding for research projects, including Canadian Institutes of Health Research (CIHR) grants, Michael Smith Health Research BC awards, and strategic research fund contributions.
2. Clinical Trial Contracts: Industry-sponsored clinical trials conducted at Providence sites, with contracts negotiated through the Contracts and Grants team.
3. Philanthropic Donations: Donations through St. Paul's Foundation to support equipment, research, and enhanced patient care at Providence Health Care facilities.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Providence Research operates the research enterprise of Providence Health Care, conducting patient-centred clinical and translational research across cardiology, respirology, nephrology, addiction medicine, and rehabilitation. It delivers research infrastructure and services including a Phase 1 Clinical Trials Unit, Biobank, Health Informatics Data Platform, Simulation Centre, wet labs, funding programs, and an AI-powered grant proposal assistant for affiliated clinician-researchers and industry partners.

Product overview

Providence Research is the research engine of Providence Health Care, operating as a unified research institute that includes multiple facilities, programs, and services. The portfolio includes clinical research facilities (the CSRC under development and the MSJ Phase 1 Clinical Trials Unit), research support services (Biobank, Researcher Directory, Clinical Trials Directory), AI-powered tools (Research Proposal Assistant using Azure-hosted LLMs), funding programs (Carraresi Foundation Award, PHC Practice Based Research Challenge), and specialized clinical programs (Road to Recovery addiction treatment, Rehab Research and Innovation Lab). The Health Informatics Data Platform and Simulation Centre round out the technology infrastructure supporting discovery science and translational research.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Support and Research Centre (CSRC)
• Mount Saint Joseph Hospital Phase 1 Clinical Trials Unit
• Research Proposal Assistant (RPA)
• Biobank

Quantifiable outcome

• B.C. achieves 55% kidney transplant rate vs 44% national average through Living Donor Circle of Excellence program
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature8 records

Partnerships

Twelve partnerships are on record, tiered core and secondary.

• University of British Columbia (UBC)coreStrategic or Co-development PartnerAcademic health science centre affiliated with UBC. The President of Providence Research serves as Associate Dean, Research for UBC Faculty of Medicine. Collaborates on research programs, trainee support, and knowledge translation through joint appointments and research agreements.
• Simon Fraser University (SFU)coreStrategic or Co-development PartnerAcademic affiliation for research and teaching. SFU faculty and students working at PHC sites are covered under Providence research policies.
• Trinity Western University (TWU)secondaryStrategic or Co-development PartnerCollaborative research partnership with TWU researchers Drs. Kendra Rieger and Sheryl Reimer-Kirkham on arts-based spiritual care study. Partnership funded through 2024 CIHR Insight Grant.
• BC Centre on Substance Use (BCCSU)coreStrategic or Co-development PartnerCollaboration on addiction medicine research including Road to Recovery Initiative evaluation. Includes partnership with BCCSU researchers on substance use treatment programs and policy development.
• Vancouver Coastal Health (VCH)coreStrategic or Co-development PartnerPartner with VCH and PHC's Regional Addiction Program (RAP) on Road to Recovery Initiative to reorganize clinical services for integrated addiction care system.
• REACH BCsecondaryChannel Partner/ Reseller/ DistributorProvincial platform connecting volunteers with clinical trial research opportunities. Used by MSJ CTU to recruit healthy volunteers for Phase 1 clinical trials.
• BC Emergency Health Services (BCEHS)coreStrategic or Co-development PartnerCollaboration on BC Resuscitation Research Collaborative (BC RESURECT) for cardiac arrest research. BCEHS paramedics participate in provincial registry data collection and research initiatives.
• Centre for Advancing Health OutcomessecondaryStrategic or Co-development PartnerResearch organization where Dr. Brian Grunau serves as Scientist. Collaborates on health outcomes research and cardiac arrest systems-level studies.
• MedtronicsecondaryTechnology or IntegrationHealthcare technology company providing Inceptiv closed-loop spinal cord stimulation devices used at St. Paul's Hospital for chronic pain management research and treatment.
• Michael Smith Genome Sciences CentresecondaryStrategic or Co-development PartnerVancouver-based genome centre where genetic testing for Dr. Elliott's kidney disease research will take place. Part of BC Cancer Agency.
• Aspect BiosystemssecondaryStrategic or Co-development PartnerVancouver-based biotechnology company pioneering bioprinted tissue therapeutics. Government of Canada also investing in Aspect through SRF to strengthen Canada's biomanufacturing sector.
• Living Donor Circle of Excellence Employer NetworksecondaryGTM or Marketing PartnerOver 235 companies have joined the program providing paid leave for living kidney donors. Includes major employers committed to supporting employee kidney donation through workplace policies.

Scale indicators7 records

Recent moves9 records

Expansion highlights7 records

Others

• Aspect Biosystems: Vancouver-based biotechnology company specializing in bioprinted tissue therapeutics. Providence names Aspect as a strategic partner on SRF-funded work; relevant as an adjacent ecosystem biotech that the CSRC Innovation Hub is positioned to commercialize with.
• Michael Smith Health Research BC: Provincial funding agency and capacity-builder for BC health research that funds Providence investigators and many of its competitor institutes. An adjacent ecosystem enabler rather than a peer competitor, but materially shapes PHC RI's grant landscape and talent pipeline.

Direct peers

• Vancouver Coastal Health Research Institute (VCHRI): The research arm of Vancouver Coastal Health, VCHRI is a same-city, sibling academic health science centre research institute with overlapping UBC affiliation, clinical trials infrastructure, and population-scale research programs. It is the most direct peer to Providence Research given geographic and organizational proximity.
• Population Health Research Institute (PHRI): Hamilton, Ontario-based clinical research enterprise jointly hosted by Hamilton Health Sciences and McMaster University. Runs large-scale multi-site clinical trials and outcomes research, paralleling PHC RI's provincial-scale cardiac arrest registry and multi-disciplinary clinical trials portfolio.
• Ottawa Hospital Research Institute (OHRI): Non-profit research institute affiliated with the University of Ottawa that operates within a major Canadian teaching hospital and conducts translational and clinical research across multiple therapeutic areas. Directly comparable in mission, university-hospital governance, and clinical-trials-driven revenue model.
• Research Institute of the McGill University Health Centre (RI-MUHC): Research arm of the McGill University Health Centre in Montreal, conducting translational and clinical research across a wide range of therapeutic specialties. Structurally analogous as a hospital-affiliated, university-linked research institute in a Canadian academic health science centre.
• BC Cancer Research Institute: Provincial cancer research organization based in Vancouver with BC-wide reach and overlapping UBC affiliation. While oncology-focused, it competes for the same investigator talent, grant funding pool, and industry-sponsored trial partnerships in British Columbia.
• Li Ka Shing Knowledge Institute / St. Michael's Hospital: Toronto-based research institute within St. Michael's Hospital, a Catholic teaching hospital affiliated with the University of Toronto. The shared faith-based hospital context and inner-city clinical population make it a strong direct peer to Providence Health Care Research Institute.

Broad incumbents

• Cedars-Sinai Medical Center: Large Los Angeles-based academic medical centre with major research programs in cardiology, nephrology, and translational medicine through the Smidt Heart Institute. Functions as a broader incumbent specializing in many of the same therapeutic areas as Providence's research centres.
• University Health Network (UHN) Research: Toronto-based UHN is Canada's largest hospital research enterprise, affiliated with the University of Toronto. It is a broader incumbent that absorbs a larger share of national clinical-trial volume and investigator talent, making it a comparator for scale rather than direct head-to-head competition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/phcresearch
• LinkedInlinkedin.com/sharing/share-offsite/?url=https://www.providenceresearch.ca/en

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Providence Health Care Research Institute